|

Allergen Immunotherapy Extract Clinical Trials

1 actively recruiting trial

Also known as: ORALTEK®

Pipeline

Phase 3: 1

Top Sponsors

  • Inmunotek S.L.1

Indications

  • Rhinitis1
  • Rhinoconjunctivitis1
  • Asthma1

Other1 trial

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.